Quantbot Technologies LP Lannett CO Inc Transaction History

Quantbot Technologies LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$4.9 - $7.12 $6,477 - $9,412	-1,322 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$6.43 - $9.86 $8,500 - $13,034	1,322 New	1,322 $9,000
Q4 2019 Feb 10, 2020	SELL	$8.49 - $12.81 $96,887 - $146,187	-11,412 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$5.58 - $14.47 $63,678 - $165,131	11,412 New	11,412 $127,000
Q2 2019 Aug 13, 2019	SELL	$5.22 - $9.08 $47,512 - $82,646	-9,102 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$5.35 - $9.82 $8,870 - $16,281	1,658 Added 22.27%	9,102 $71,000
Q4 2018 Feb 13, 2019	BUY	$3.43 - $6.19 $3,869 - $6,982	1,128 Added 17.86%	7,444 $36,000
Q3 2018 Nov 13, 2018	BUY	$4.75 - $14.5 $30,001 - $91,582	6,316 New	6,316 $30,000
Q2 2018 Aug 13, 2018	SELL	$13.3 - $17.45 $164,494 - $215,821	-12,368 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$14.7 - $24.95 $150,116 - $254,789	10,212 Added 473.65%	12,368 $198,000
Q4 2017 Feb 12, 2018	BUY	$19.9 - $29.25 $42,904 - $63,063	2,156	2,156 $50,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.